期刊文献+

A型肉毒毒素治疗头-颈部运动病变 被引量:2

Botulium A Toxin treatment for cranial-cervical movement disorders
下载PDF
导出
摘要 目的 探讨 A型肉毒毒素 ( BTX- A)治疗头 -颈部运动病变的临床疗效和不良反应。方法 对 193例患者 (其中面肌痉挛 12 7例、眼睑痉挛 3 1例、Meige综合征 2 9例、痉挛性斜颈 6例 )采用局部多点注射法于痉挛肌肉注射 BTX- A,并随访观察。结果 面肌痉挛、眼睑痉挛和 Meige综合征的治疗有效率均为 10 0 % ,作用持续时间分别是 ( 15 .8± 5 .0 )周、( 13 .4 7± 8.1)周和 ( 12 .3±2 .3 )周 ;痉挛性斜颈的治疗有效率为 83 .4 % ,作用持续时间为 ( 17.1± 5 .7)周。副作用局限、轻微且可逆。结论  BTX- A局部注射治疗头 -颈部运动病变的首选方法之一。 Objective To evaluate the clinical efficacy and side effects of botulinum toxin type A (BTX A) injections for treatment of cranial cervical movement disorders.Methods One hundred and ninety three patients were treated with multifocal intramuscular injections of small doses of BTX A in spasm muscles and followed up.Results Of 127 cases with hemifacial spasm, 31 blepharospasm and 29 Meige's syndrome, the effective rates were all 100% and the average relief duration was(15.8±5.0)wk,(13.4±8.1)wk and (12.3±2.3)wk, respectively. Of 9 cases with spasmodic torticollis, the effective rate was 83.4%, and the average relief duration was( 17.1±5.7)wk. The side effects were local, mild, transient and reversible. Conclusions The local injection of BTX A is a safe and effective means for the treatment of cranial cervical dystonia.
出处 《临床内科杂志》 CAS 北大核心 2001年第6期465-466,共2页 Journal of Clinical Internal Medicine
关键词 A型肉毒毒素 运动病变 治疗 疗效 Botulinum toxin type A Movement disorder
  • 相关文献

参考文献3

  • 1Cohen DA,Savino P,Stern MB,et al.Botulinum injection therapy for blepharospasm: a review and report of 75 patients[].Clinical Neuropharmacology.1986
  • 2Tsui JK,Eisen A,Stoessl AJ.Double -blind study of botulinum toxin in spasmodic torticollis[].The Lancet.1986
  • 3Olney RK,Aminoff MJ,Lowenstein DH.Neuromuscular effects distant from the site of botulinum neurotoxin injection[].Neurology.1997

同被引文献24

  • 1汤晓芙,万新华.A型肉毒毒素治疗局限性肌张力障碍与面肌痉挛[J].中华神经科杂志,1996,29(2):111-114. 被引量:117
  • 2黄坤,段云平,高宝山,钱盛伟,常庆勇,张继志,金点石,曲凯.微血管减压术治疗面肌痉挛并耳聋、耳鸣[J].中华神经医学杂志,2007,6(8):819-821. 被引量:8
  • 3Valls-Solé J.Electrodingnostic studies of the facial nerve in peripheral facial palsy and hemffacial spasm.Muscle Nerve,2007,36:14-20.
  • 4Ⅱlingworth RD,Porter DG,Jakubowski J.Hemifacial spasm:a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom.J Neurol Neurosurg Psychiatry,1996,60:72-77.
  • 5Wang A,Jankovic J.Hemifacial spasm:clinical findings and treatment.Muscle Nerve,1998,21:1740-1747.
  • 6Kiziltan M,Sahin R,Uzun N,et al.Hemifacial spasm and posterior auricular muscle.Electromyogr Clin Neurophysiol,2006,46:317-320.
  • 7Cohen DA,Savino P,Stem MB,et al.Botulinum injection therapy for blepharospasm:a review and report of 75 patients.Clin Neuropharmacol,1986,9:415-429.
  • 8Simpson DM,Blitzer A,Brashear A,et al.Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Assessment:Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review):report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Neurology,2008,70:1699-1706.
  • 9Jiménez-Escrig A,San-Millan JM,Barón M.Oculo-auricular phenomenon secondary to vestibular dysfunction.Mov Discrd,2002,17:1394-1395.
  • 10Ogawara K,Kuwabara S,Kamitsukasa I,et al.Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm.Neurology,2004,62:1749-1752.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部